146 related articles for article (PubMed ID: 30068521)
1. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells.
Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521
[TBL] [Abstract][Full Text] [Related]
2. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells].
Iwao T
Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes.
Kodama N; Iwao T; Kabeya T; Horikawa T; Niwa T; Kondo Y; Nakamura K; Matsunaga T
Drug Metab Pharmacokinet; 2016 Jun; 31(3):193-200. PubMed ID: 27161454
[TBL] [Abstract][Full Text] [Related]
4. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds.
Iwao T; Kodama N; Kondo Y; Kabeya T; Nakamura K; Horikawa T; Niwa T; Kurose K; Matsunaga T
Drug Metab Dispos; 2015 Apr; 43(4):603-10. PubMed ID: 25650381
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells.
Kabeya T; Mima S; Imakura Y; Miyashita T; Ogura I; Yamada T; Yasujima T; Yuasa H; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2020 Aug; 35(4):374-382. PubMed ID: 32651148
[TBL] [Abstract][Full Text] [Related]
6. Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction.
Takayama K; Negoro R; Yamashita T; Kawai K; Ichikawa M; Mori T; Nakatsu N; Harada K; Ito S; Yamada H; Yamaura Y; Hirata K; Ishida S; Mizuguchi H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):513-526. PubMed ID: 31228606
[TBL] [Abstract][Full Text] [Related]
7. Air-liquid interface culture and modified culture medium promote the differentiation of human induced pluripotent stem cells into intestinal epithelial cells.
Shirai K; Qiu S; Minowa H; Hashita T; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2024 Apr; 55():100994. PubMed ID: 38452616
[TBL] [Abstract][Full Text] [Related]
8. Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kodama N; Iwao T; Katano T; Ohta K; Yuasa H; Matsunaga T
Drug Metab Dispos; 2016 Oct; 44(10):0. PubMed ID: 27417181
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method.
Iwao T; Toyota M; Miyagawa Y; Okita H; Kiyokawa N; Akutsu H; Umezawa A; Nagata K; Matsunaga T
Drug Metab Pharmacokinet; 2014; 29(1):44-51. PubMed ID: 23822979
[TBL] [Abstract][Full Text] [Related]
10. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Human Jejunal Spheroid-Derived Differentiated Intestinal Epithelial Cells for the Prediction of Intestinal Drug Absorption in Humans.
Michiba K; Maeda K; Shimomura O; Miyazaki Y; Hashimoto S; Oda T; Kusuhara H
Drug Metab Dispos; 2022 Mar; 50(3):204-213. PubMed ID: 34992074
[TBL] [Abstract][Full Text] [Related]
12. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
13. Utility of human induced pluripotent stem cell-derived small intestinal epithelial cells for pharmacokinetic, toxicological, and immunological studies.
Imakura Y; Mima S; Yamazaki N; Inomata A; Mochizuki S; Iwao T; Matsunaga T
Biochem Biophys Res Commun; 2024 Jan; 692():149356. PubMed ID: 38071890
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cells.
Janssen AWF; Duivenvoorde LPM; Rijkers D; Nijssen R; Peijnenburg AACM; van der Zande M; Louisse J
Arch Toxicol; 2021 Mar; 95(3):907-922. PubMed ID: 33263786
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells.
Kondo S; Mizuno S; Hashita T; Iwao T; Matsunaga T
Biol Open; 2020 Jan; 9(1):. PubMed ID: 31919043
[TBL] [Abstract][Full Text] [Related]
16. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes.
Kabeya T; Matsumura W; Iwao T; Hosokawa M; Matsunaga T
Biochem Biophys Res Commun; 2017 Apr; 486(1):143-148. PubMed ID: 28285137
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-dependent protein kinase A negatively modulates adherens junction integrity and differentiation of intestinal epithelial cells.
Boucher MJ; Laprise P; Rivard N
J Cell Physiol; 2005 Jan; 202(1):178-90. PubMed ID: 15389533
[TBL] [Abstract][Full Text] [Related]
19. Toward Xeno-Free Differentiation of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.
Saari J; Siddique F; Korpela S; Mäntylä E; Ihalainen TO; Kaukinen K; Aalto-Setälä K; Lindfors K; Juuti-Uusitalo K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163236
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450-dependent drug oxidation activities in commercially available hepatocytes derived from human induced pluripotent stem cells cultured for 3 weeks.
Murayama N; Yamazaki H
J Toxicol Sci; 2018; 43(4):241-245. PubMed ID: 29618712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
